Kalydeco Marks the Latest Success of the Cystic Fibrosis Foundation’s Venture Philanthropy Model
Site Search
Showing 1 - 8 of 8 results
Press Release
|
|
2 min read
Press Release
|
|
5 min read
CF Foundation Provided Scientific, Clinical and Significant Funding Support in Drug Development Process
Press Release
|
|
5 min read
Press Release
|
|
3 min read
This medicine represents the single greatest therapeutic advancement in the history of CF, offering a treatment for the underlying cause of the disease that could eventually benefit more than 90 percent of people with CF.
Press Release
|
|
3 min read
Drug Targets the Underlying Cause of the Disease in People with the Most Common CF Mutation
Press Release
|
|
5 min read
Press Release
|
|
3 min read
As a clinician, you're critical in helping people with CF maintain their quality of life. We're committed to helping you partner with your patients and their families by providing resources you can use to improve and continue to provide high-quality care.